π¬ Current Disease Focus:
Task Progress: 0%
π₯ Active Problem Solvers
0
π Experts collaborating globally
β‘ Current Task Assignment
𧬠Genetic Analysis
π Matching experts to specific tasks
π Resource Allocation by Research Phase:
π Data Analysis
π§ͺ Experimental Design
π¬ Clinical Trials
π Treatment Development
This phase II trial compares three chemotherapy regimens consisting of bend...
Status
Active Not Recruiting
Location
Anchorage Associates in Radiation Medicine
Start Date
2019-12-13
Trial ID
NCT04115631
Treatments Being Tested
The purpose of this study is to determine the efficacy of SyB L-0501 in com...
Status
Completed
Location
Multiple Locations
Start Date
2010-04
Trial ID
NCT01118845
Treatments Being Tested
The purpose of this study is to determine the antitumor efficacy and safety...
Status
Completed
Location
Multiple Locations
Start Date
2011-11
Trial ID
NCT01849848
Treatments Being Tested
This phase II trial investigates how well brentuximab vedotin and bendamust...
Status
Recruiting
Location
University of California Davis Comprehensive Cancer Center
Start Date
2020-12-04
Trial ID
NCT04587687
Treatments Being Tested
This phase I/II trial studies the side effects and the best dose of inotuzu...
Status
Completed
Location
M D Anderson Cancer Center
Start Date
2012-10-29
Trial ID
NCT01664910
This phase II trial studies how well obinutuzumab with or without umbralisi...
Status
Active Not Recruiting
Location
Alaska Breast Care and Surgery LLC
Start Date
2018-01-23
Trial ID
NCT03269669
The purpose of this study is to assess the efficacy and safety of SyB L-050...
Status
Completed
Location
Research site
Start Date
2011-11
Trial ID
NCT01718691
Treatments Being Tested
The purpose of this study is to assess the antitumor effects and safety of ...
Status
Completed
Location
Multiple Locations
Start Date
2007-12
Trial ID
NCT00612183
Treatments Being Tested
The study objectives of this study are to determine the effects, safety, an...
Status
Terminated
Location
Research site
Start Date
2010-09
Trial ID
NCT01179490
Treatments Being Tested
This phase II trial studies how well bendamustine hydrochloride, obinutuzum...
Status
Terminated
Location
University of Chicago Comprehensive Cancer Center
Start Date
2015-11
Trial ID
NCT02420210